J. Amann

D. Carbone, K. Shilo, Taek-Kyun Kim, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Liver‐specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks

S. Hiebert, S. Huppert, S. K. Knutson, 2008, The EMBO journal.

ETO, a Target of t(8;21) in Acute Leukemia, Makes Distinct Contacts with Multiple Histone Deacetylases and Binds mSin3A through Its Oligomerization Domain

James R. Downing, Hironori Harada, J. Downing, 2001, Molecular and Cellular Biology.

Predicting ROR1/BCL2 combination targeted therapy of small cell carcinoma of the lung

C. Croce, D. Carbone, K. Shilo, 2021, Cell Death & Disease.

Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC

Jason V. Evans, P. Fadda, D. Carbone, 2018, Nature Communications.

Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control.

D. Cortez, S. Hiebert, Zu-Wen Sun, 2008, Molecular cell.

LKB1 Loss Induces Characteristic Patterns of Gene Expression in Human Tumors Associated with NRF2 Activation and Attenuation of PI3K-AKT

D. Carbone, Y. Shyr, Haotian Li, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Rad51C-ATXN7 fusion gene expression in colorectal tumors

S. P. Nana-Sinkam, G. Otterson, Qi-En Wang, 2016, Molecular Cancer.

In-depth Proteomic Analysis of Nonsmall Cell Lung Cancer to Discover Molecular Targets and Candidate Biomarkers*

P. Massion, D. Carbone, R. Slebos, 2012, Molecular & Cellular Proteomics.

Deletion of Mtgr1 sensitizes the colonic epithelium to dextran sodium sulfate-induced colitis.

M. Washington, S. Hiebert, Christopher S. Williams, 2006, Gastroenterology.

Mtgr1 Is a Transcriptional Corepressor That Is Required for Maintenance of the Secretory Cell Lineage in the Small Intestine

M. Washington, S. Gautam, R. Coffey, 2005, Molecular and Cellular Biology.

Small Cell Lung Cancer: Subtypes and Therapeutic Implications.

D. Carbone, P. Tsichlis, J. Amann, 2022, Seminars in cancer biology.

STK11/LKB1 Loss of Function Is Associated with Global DNA Hypomethylation and S-Adenosyl-Methionine Depletion in Human Lung Adenocarcinoma

Michael F. Sharpnack, M. Gerstein, Fábio C. P. Navarro, 2021, Cancer Research.

Proteogenomic Analysis of Surgically Resected Lung Adenocarcinoma

Michael F. Sharpnack, K. Coombes, J. Sharpnack, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Genomic Characterization of Non-Small-Cell Lung Cancer in African Americans by Targeted Massively Parallel Sequencing.

K. Coombes, D. Carbone, K. Shilo, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Circulating miRNAs and extracellular vesicle containing miRNAs as response biomarkers of anti PD-1/PD-L1 therapy in non-small-cell lung cancer.

D. Carbone, K. Shilo, T. Shukuya, 2020, Journal of Thoracic Oncology.

Comparison of Tumor Microenvironments Between Primary Tumors and Brain Metastases in Patients With NSCLC

D. Carbone, T. Shukuya, T. Nakatsura, 2021, JTO clinical and research reports.

An immunogold single extracellular vesicular RNA and protein (AuSERP) biochip to predict responses to immunotherapy in non‐small cell lung cancer patients

D. Carbone, A. Palmer, Luong T H Nguyen, 2021, bioRxiv.

The Effect of LKB1 Activity on the Sensitivity to PI3K/mTOR Inhibition in Non-Small Cell Lung Cancer.

Fuhai Li, D. Carbone, Tadaaki Yamada, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Impact of Pre-Analytical Variables on Cancer Targeted Gene Sequencing Efficiency

Lianbo Yu, Ayse Selen Yilmaz, Weiqiang Zhao, 2015, PloS one.

Myeloid Translocation Gene Family Members Associate with T-Cell Factors (TCFs) and Influence TCF-Dependent Transcription

Ethan Lee, S. Hiebert, Emilios Tahinci, 2007, Molecular and Cellular Biology.

Histone Deacetylase Inhibition Enhances the Antitumor Activity of a MEK Inhibitor in Lung Cancer Cells Harboring RAS Mutations

D. Carbone, K. Shilo, S. Yano, 2017, Molecular Cancer Therapeutics.

Novel strategies for the treatment of lung cancer: modulation of eicosanoids.

M. Backlund, J. Amann, David H. Johnson, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Relationship between Overall Survival and Response or Progression‐Free Survival in Advanced Non–Small Cell Lung Cancer Patients Treated with Anti–PD‐1/PD‐L1 Antibodies

D. Carbone, P. Shields, G. Otterson, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinoma.

M. Meyerson, H. Greulich, M. Imieliński, 2014, The Journal of clinical investigation.

RANBP9 as potential therapeutic target in non-small cell lung cancer

R. Visone, D. Carbone, V. Coppola, 2020, Journal of cancer metastasis and treatment.

Selective Profiling of Proteins in Lung Cancer Cells from Fine-Needle Aspirates by Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry

P. Chaurand, R. Caprioli, P. Massion, 2006, Clinical Cancer Research.

Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer.

D. Carbone, H. Tai, D. Billheimer, 2007, Cancer research.

Co‐Expression Analysis Reveals Mechanisms Underlying the Varied Roles of NOTCH1 in NSCLC

K. Coombes, D. Carbone, Ferdinando Cerciello, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Identification of Recurrent Activating HER2 Mutations in Primary Canine Pulmonary Adenocarcinoma

Winnie S. Liang, J. Trent, D. Carbone, 2019, Clinical Cancer Research.

Genetic and Proteomic Features Associated with Survival after Treatment with Erlotinib in First-Line Therapy of Non-small Cell Lung Cancer in Eastern Cooperative Oncology Group 3503

D. Carbone, Adriana L. Gonzalez, J. Schiller, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Identification of frequent activating HER2 mutations in primary canine pulmonary adenocarcinoma

Winnie S. Liang, J. Trent, D. Carbone, 2019, bioRxiv.

Acquired EGFr TKI resistance associated with mutation of the EGFr.

D. Carbone, J. Ohm, J. Amann, 2004 .

Notch 3-Dependent Signaling like Cells through − EGFR Blockade Enriches for Lung Cancer Stem

D. Carbone, M. Rahman, S. Huppert, 2014 .

A Transcriptional Signature Identifies LKB1 Functional Status as a Novel Determinant of MEK Sensitivity in Lung Adenocarcinoma.

D. Carbone, Tadaaki Yamada, C. Timmers, 2017, Cancer research.

Relationship between Overall Survival and Response or Progression‐Free Survival in Advanced Non–Small Cell Lung Cancer Patients Treated with Anti–PD‐1/PD‐L1 Antibodies

D. Carbone, P. Shields, G. Otterson, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control.

D. Cortez, S. Hiebert, Zu-Wen Sun, 2008, Molecular cell.

Liver‐specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks

S. Hiebert, S. Huppert, S. K. Knutson, 2008, The EMBO journal.

EGFR blockade enriches for lung cancer stem-like cells through Notch3-dependent signaling.

D. Carbone, M. Rahman, S. Huppert, 2014, Cancer research.

Improving combination therapies: targeting A2B-adenosine receptor to modulate metabolic tumor microenvironment and immunosuppression

Jason V. Evans, D. Carbone, J. Zweier, 2023, Journal of the National Cancer Institute.